These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7514830)

  • 1. Fine needle aspiration biopsy of hepatocellular carcinoma. Diagnostic dilemma at the ends of the spectrum.
    Wee A; Nilsson B; Tan LK; Yap I
    Acta Cytol; 1994; 38(3):347-54. PubMed ID: 7514830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
    Radhika NS; Duseja A; Rajwanshi A; Gupta SK; Sehgal S; Suri S; Chawla Y
    Trop Gastroenterol; 2004; 25(3):116-20. PubMed ID: 15682657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytologic features and histologic correlations of microacinar and microtrabecular types of well-differentiated hepatocellular carcinoma in fine-needle aspiration biopsy.
    Yang GC; Yang GY; Tao LC
    Cancer; 2004 Feb; 102(1):27-33. PubMed ID: 14968415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
    Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
    Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine needle aspiration biopsy of hepatocellular carcinoma. Value of immunocytochemical and ultrastructural studies.
    Guindi M; Yazdi HM; Gilliatt MA
    Acta Cytol; 1994; 38(3):385-91. PubMed ID: 7514832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine needle aspiration biopsy of hepatocellular carcinoma. Some unusual features.
    Wee A; Nilsson B; Chan-Wilde C; Yap I
    Acta Cytol; 1991; 35(6):661-70. PubMed ID: 1659093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.
    Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Takasaki K; Takenami K; Yamamoto M; Nakano M
    Cancer; 2000 Feb; 88(3):544-9. PubMed ID: 10649245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
    Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
    de Boer WB; Segal A; Frost FA; Sterrett GF
    Cancer; 2000 Oct; 90(5):273-8. PubMed ID: 11038423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
    Peng YC; Chan CS; Chen GH
    Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma.
    Bialecki ES; Ezenekwe AM; Brunt EM; Collins BT; Ponder TB; Bieneman BK; Di Bisceglie AM
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):361-8. PubMed ID: 16527701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
    Farinati F; Marino D; De Giorgio M; Baldan A; Cantarini M; Cursaro C; Rapaccini G; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M; Trevisani F
    Am J Gastroenterol; 2006 Mar; 101(3):524-32. PubMed ID: 16542289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of preoperative fine-needle aspiration cytologic examination on clinical outcome in patients with hepatocellular carcinoma in a tertiary referral center.
    Ng KK; Poon RT; Lo CM; Liu CL; Lam CM; Ng IO; Fan ST
    Arch Surg; 2004 Feb; 139(2):193-200. PubMed ID: 14769580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markedly elevated alpha-fetoprotein levels without hepatocellular carcinoma.
    Cheema AW; Hirschtritt T; Van Thiel DH
    Hepatogastroenterology; 2004; 51(60):1676-8. PubMed ID: 15532803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 70-year-old woman with 10 years of markedly elevated alpha-fetoprotein measurements.
    Hsu SX; Siegel AB; Berk PD
    Semin Liver Dis; 2010 Feb; 30(1):99-106. PubMed ID: 20175037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
    Nouso K; Urabe Y; Higashi T; Nakatsukasa H; Hino N; Ashida K; Kinugasa N; Yoshida K; Uematsu S; Tsuji T
    Cancer; 1996 Jul; 78(2):232-36. PubMed ID: 8673997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.